Paip1 affects breast cancer cell growth and represents a novel prognostic biomarker
Paip1 affects breast cancer cell growth and represents a novel prognostic biomarker
复制标题
Paip1 影响乳腺癌细胞生长并代表一种新型预后生物标志物
DOI:
10.1016/j.humpath.2017.10.037
复制
发表时间:
2018-03-01
期刊:
影响因子:
3.3
通讯作者:
Lin, Zhenhua
中科院分区:
文献类型:
--
作者:
Piao, Junjie;Chen, Liyan;Lin, Zhenhua
Polyadenylate-binding protein-interacting protein 1 (Paipl) regulates translational initiation. Increasing evidence suggests that Paipl plays important roles in cancer development and progression. This study explored the role of Paipl in breast cancer progression and evaluated its prognostic value. The cellular location of Paipl protein was determined using immunofluorescence. Then, Paip1 protein expression was evaluated by immunohistochemical staining in 119 breast cancers and 40 normal breast tissues. The correlation between Paipl expression and the clinicopathologic features of breast cancer was evaluated using the chi(2) test, and differences in survival curves were analyzed using log-rank tests. The role of Paipl in breast cancer proliferation and cell cycle progression was identified by siRNA transfection. Paip1 was expressed mainly in the cytoplasm of cancer cells and tissues. Expression was observed in 60.5% of the breast cancers (72/119), which was significantly higher than in normal breast tissues (17.5%; 7/40). High expression of Paipl protein was associated with high histologic grade, late clinical stage, and a low survival rate. Multivariate analysis indicated that Paip1 was an independent prognostic factor. Additionally, Paipl depletion by RNAi significantly decreased cell proliferation and induced cell cycle arrest. In conclusion, our study demonstrated that Paipl promotes the growth of breast cancers and could be a prognostic biomarker and therapeutic target. (C) 2017 Elsevier Inc. All rights reserved.